Krebs Biochemicals & Industries Limited (BOM:524518)
India flag India · Delayed Price · Currency is INR
59.25
+3.00 (5.33%)
At close: Feb 12, 2026

BOM:524518 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
-269.39-197.28-246.92-445.27-283.59
Depreciation & Amortization
65.0565.8263.7556.5848.64
Other Amortization
1.841.841.846.392.6
Loss (Gain) From Sale of Assets
-1.22----
Other Operating Activities
58.4251.1832.5951.1465.52
Change in Accounts Receivable
18.53-13.783.51-5.77-0.98
Change in Inventory
37.6521.49136.17-89.62-16.05
Change in Accounts Payable
-8.1836.89-226.26171.3-18.71
Change in Other Net Operating Assets
18.3857.49-11.8183.0956.82
Operating Cash Flow
-78.9123.65-247.13-172.16-145.75
Capital Expenditures
-35.63-94.15-151.58-270.78-255.06
Sale of Property, Plant & Equipment
1.6420.88---
Other Investing Activities
-15.7-4.8925.1341.7929.57
Investing Cash Flow
-49.7-78.17-126.45-229-225.49
Short-Term Debt Issued
410.29----
Long-Term Debt Issued
-102.54403.17323.84334.91
Total Debt Issued
410.29102.54403.17323.84334.91
Short-Term Debt Repaid
--0.61---
Long-Term Debt Repaid
-222.5----
Total Debt Repaid
-222.5-0.61---
Net Debt Issued (Repaid)
187.79101.93403.17323.84334.91
Issuance of Common Stock
---125.13104.49
Other Financing Activities
-59.14-46.89-29.73-53.91-62.79
Financing Cash Flow
128.6555.03373.43395.06376.61
Miscellaneous Cash Flow Adjustments
-00--
Net Cash Flow
0.040.52-0.15-6.15.36
Free Cash Flow
-114.54-70.5-398.71-442.95-400.81
Free Cash Flow Margin
-26.45%-13.98%-76.48%-74.19%-76.08%
Free Cash Flow Per Share
-5.31-3.27-18.49-20.54-20.43
Cash Interest Paid
59.0846.8629.7153.8562.72
Cash Income Tax Paid
0.15----
Levered Free Cash Flow
-57.76-37.27-336.06-332.22-449.94
Unlevered Free Cash Flow
-20.84-7.98-317.49-298.57-410.75
Change in Working Capital
66.39102.1-98.3815921.08
Source: S&P Global Market Intelligence. Standard template. Financial Sources.